[go: up one dir, main page]

MX2016013428A - Composiciones farmaceuticas que comprenden agentes antibacterianos. - Google Patents

Composiciones farmaceuticas que comprenden agentes antibacterianos.

Info

Publication number
MX2016013428A
MX2016013428A MX2016013428A MX2016013428A MX2016013428A MX 2016013428 A MX2016013428 A MX 2016013428A MX 2016013428 A MX2016013428 A MX 2016013428A MX 2016013428 A MX2016013428 A MX 2016013428A MX 2016013428 A MX2016013428 A MX 2016013428A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
antibacterial agents
pharmaceutically acceptable
acceptable derivative
ceftolozane
Prior art date
Application number
MX2016013428A
Other languages
English (en)
Inventor
Vithalbhai Patel Mahesh
Bhagwat Sachin
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2016013428A publication Critical patent/MX2016013428A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen composiciones farmacéuticas que comprenden ceftolozane o un derivado farmacéuticamente aceptable, y un compuesto de la Fórmula (I) o un estereoisómero o un derivado farmacéuticamente aceptable del mismo. (ver Fórmula).
MX2016013428A 2014-04-18 2015-03-25 Composiciones farmaceuticas que comprenden agentes antibacterianos. MX2016013428A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1408MU2014 2014-04-18
PCT/IB2015/052171 WO2015159167A1 (en) 2014-04-18 2015-03-25 Pharmaceutical compositions comprising antibacterial agents

Publications (1)

Publication Number Publication Date
MX2016013428A true MX2016013428A (es) 2017-04-13

Family

ID=52988354

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013428A MX2016013428A (es) 2014-04-18 2015-03-25 Composiciones farmaceuticas que comprenden agentes antibacterianos.

Country Status (8)

Country Link
US (1) US20170027917A1 (es)
EP (1) EP3131555A1 (es)
JP (1) JP2017511359A (es)
KR (1) KR20160138304A (es)
CN (1) CN106659718A (es)
BR (1) BR112016024236A2 (es)
MX (1) MX2016013428A (es)
WO (1) WO2015159167A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
IL280770B2 (en) 2018-08-09 2024-05-01 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101418015B (zh) * 2007-10-24 2011-04-27 山东轩竹医药科技有限公司 头孢曲松磷酰化衍生物
NZ596628A (en) * 2009-05-27 2013-03-28 Ketolide compounds having antimicrobial activity
EP3052497B1 (en) * 2011-09-13 2017-06-28 Wockhardt Limited Nitrogen containing compounds and their use

Also Published As

Publication number Publication date
US20170027917A1 (en) 2017-02-02
BR112016024236A2 (pt) 2017-08-15
WO2015159167A1 (en) 2015-10-22
CN106659718A (zh) 2017-05-10
JP2017511359A (ja) 2017-04-20
KR20160138304A (ko) 2016-12-02
EP3131555A1 (en) 2017-02-22

Similar Documents

Publication Publication Date Title
MY195977A (en) Heterocyclic Compounds and uses Thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
MX2016016593A (es) Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos.
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MA39749A (fr) Dérivés de pipéridine-dione
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
PH12020551586A1 (en) Oxysterols and methods of use thereof
MY181641A (en) Amino pyran ring derivative and composition and use thereof
MY162886A (en) Novel tetrahydropyridopyrimidine compound or salt thereof
MX2018014813A (es) Composiciones antibacterianas.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
EP3720844A4 (en) MEDICINAL COMPOSITIONS
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
IN2014MU00859A (es)
MX2016005160A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2013MU03704A (es)
MX2016005539A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
NZ719215A (en) Pharmaceutical compositions comprising antibacterial agents
IN2013MU03421A (es)
MX2017010992A (es) Composiciones farmaceuticas estables que comprenden agente antibacteriano.
MX2018010652A (es) Composiciones farmaceuticas.
IN2014MU01194A (es)
HK40094583A (zh) 包含美洛昔康的药物组合物
HK40093239A (zh) 包含美洛昔康的药物组合物